USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: Investigen, Inc.
Address: 750 ALFRED NOBEL DRIVE, SUITE 109
HERCULES, CA 94547-
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,267,387.00 6
SBIR Phase II $1,499,977.00 2

Award List:

Fast, easy, reliable first responder bioterrorism detection system

Award Year / Program / Phase: 2005 / SBIR / Phase I
Agency: DHS
Principal Investigator: Zwick Michael, VP New Technologies – (510) 964-9700
Award Amount: $99,600.00
Abstract:
The proposed research is to determine feasibility of developing a stable, simple, rapid method of detecting the nucleic acid (NA) from bioterrorism agents. This method would be based on Investigen?s novel and elegant ?smartDNA? technology. This system utilizes a peptide nucleic acid probe cocktail… More

Easy, fast, point of care nucleic acid based detection of pulmonary tuberculosis

Award Year / Program / Phase: 2006 / SBIR / Phase I
Agency: HHS
Principal Investigator: Peter J. Dailey
Award Amount: $99,550.00
Abstract:
DESCRIPTION (provided by applicant): The proposed research is to determine the feasibility of developing a novel, simple, rapid method of detecting the nucleic acid (NA) from Mycobacterium tuberculosis cell in sputum, for detection of pulmonary tuberculosis (TB). This method would be based on… More

Rapid, easy nucleic acid-based detection of pulmonary tuberculosis

Award Year / Program / Phase: 2007 / SBIR / Phase II
Agency: HHS
Principal Investigator: Heather Koshinsky
Award Amount: $749,977.00
Abstract:
DESCRIPTION (provided by applicant): With nearly one-third of the world's population (2 billion people) infected, tuberculosis (TB) is a major problem for global public health. The WHO estimates that each year 12 million people progress to active TB and 2 million of these people will die (WHO50/50,… More

Fast, Easy, Reliable First Responder Bioterrorism Detection System

Award Year / Program / Phase: 2008 / SBIR / Phase II
Agency: DHS
Principal Investigator: Rachel Holmes-Davis, Scientist – (510) 964-9700
Award Amount: $750,000.00
Abstract:
The proposed research is to develop the prototype of a handheld first responder bioterrorism agent (BA) detection system that is threat level responsive, simple, stable and rapid for analyzing suspicious powders or aerosols for the presence of nucleic acid (NA) from BAs. Investigen¿s ¿smartDNA¿… More

A rapid, POC array MDR/XDR-TB genotyping.

Award Year / Program / Phase: 2008 / SBIR / Phase I
Agency: HHS
Principal Investigator: Heather Koshinsky
Award Amount: $576,316.00
Abstract:
DESCRIPTION (provided by applicant): The diagnosis of tuberculosis (TB) is the major weak link in global TB control. Drug resistant TB compounds diagnosis and treatment challenges. The most widely used diagnostic test, sputum smear microscopy, is cumbersom e, insensitive, involves multiple patient… More

Applicability of smartDNA Rapid Detection of Priority Agents in Food

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: HHS
Principal Investigator: Richard Blidner
Award Amount: $98,947.00
Abstract:
DESCRIPTION (provided by applicant): While the United States food supply is among the safest in the world it is vulnerable to terrorist attacks as well as occasional accidental contamination from inadequate sanitation at packing and manufacturing facilitie s; e.g. the recent E. coli contamination of… More

Utility of smartDNA with Sputum Smears

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: HHS
Principal Investigator: Heather Koshinsky
Award Amount: $144,947.00
Abstract:
DESCRIPTION (provided by applicant): The diagnosis of tuberculosis (TB) is a major weak link in global TB control. Drug resistant TB compounds diagnosis and treatment challenges. The most widely used diagnostic test. Sputum smear microscopy, cannot detect multi drug or extensively drug resistant TB… More

Inexpensive multiplexed ligation probe assay to genotype drug resistant M.tubberc

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: HHS
Principal Investigator: Heather Koshinsky – 510-964-9700
Award Amount: $248,027.00
Abstract:
DESCRIPTION (provided by applicant): Diagnosis of tuberculosis (TB) is the weakest link in global TB control and drug resistance complicates the selection of an appropriate treatment course. The most widely used diagnostic test, sputum smear microscopy, iscumbersome, insensitive, involves multiple… More